Growth Metrics

Volitionrx (VNRX) Share-based Compensation (2019 - 2025)

Volitionrx's Share-based Compensation history spans 9 years, with the latest figure at -$132875.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 140.79% year-over-year to -$132875.0; the TTM value through Dec 2025 reached $1.5 million, up 14.8%, while the annual FY2025 figure was $1.7 million, 37.14% up from the prior year.
  • Share-based Compensation reached -$132875.0 in Q4 2025 per VNRX's latest filing, down from $812045.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $915031.0 in Q1 2022 to a low of -$132875.0 in Q4 2025.
  • Average Share-based Compensation over 5 years is $512705.1, with a median of $537980.0 recorded in 2023.
  • The largest YoY upside for Share-based Compensation was 290.32% in 2025 against a maximum downside of 140.79% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $276729.0 in 2021, then surged by 155.21% to $706249.0 in 2022, then plummeted by 34.06% to $465734.0 in 2023, then tumbled by 30.06% to $325738.0 in 2024, then tumbled by 140.79% to -$132875.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Share-based Compensation are -$132875.0 (Q4 2025), $812045.0 (Q2 2025), and $451374.0 (Q1 2025).